Cargando…
Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
BACKGROUND & OBJECTIVES: Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057376/ https://www.ncbi.nlm.nih.gov/pubmed/36629188 http://dx.doi.org/10.4103/ijmr.ijmr_3428_21 |
_version_ | 1785016350431772672 |
---|---|
author | Kshatri, Jaya Singh Bhattacharya, Debdutta Giri, Sidhartha Palo, Subrata Kumar Kanungo, Srikanta Mansingh, Asit Parai, Debaprasad Dany, Subha Soumya Bisoyee, Anjan Choudhary, Hari Ram Sinha, Abhinav Sahoo, Rakesh Kumar Bhoi, Trilochan Mohanta, Amiya Ranjan Ota, Akhila Bihari Mohanty, Bigyanananda Sahoo, Uttam Kumar Pati, Sanghamitra |
author_facet | Kshatri, Jaya Singh Bhattacharya, Debdutta Giri, Sidhartha Palo, Subrata Kumar Kanungo, Srikanta Mansingh, Asit Parai, Debaprasad Dany, Subha Soumya Bisoyee, Anjan Choudhary, Hari Ram Sinha, Abhinav Sahoo, Rakesh Kumar Bhoi, Trilochan Mohanta, Amiya Ranjan Ota, Akhila Bihari Mohanty, Bigyanananda Sahoo, Uttam Kumar Pati, Sanghamitra |
author_sort | Kshatri, Jaya Singh |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated the seroprevalence of COVID-19 antibodies in the tribal population of Odisha post-second wave (September 2021). METHODS: A population-based, age-stratified, cross-sectional study design was adopted for the survey, carried out in seven tribal districts of Odisha from 30(th) August to 16(th) September 2021. A multistage random sampling method was used where serum samples were tested for antibodies against the SARS-CoV-2 nucleocapsid (N) protein in each district, and a weighted seroprevalence with 95 per cent confidence interval (CI) was estimated for each district. RESULTS: A total of 2855 study participants were included from the seven tribal districts of Odisha in the final analysis. The overall weighted seroprevalence was 72.8 per cent (95% CI: 70.1-75.3). Serological prevalence was the highest among 18-44 yr (74.4%, 95% CI: 71.3-77.3) and from Sambalpur district [75.90% (66.90-83.10)]. Among participants, 41.93 per cent had received at least one dose of any COVID-19 vaccine. Kandhamal district had the highest number of fully immunized participants (24.78%), and in Sundergarh district, most of the study participants (58.1%) were unimmunized. INTERPRETATION & CONCLUSIONS: This study found high seroprevalence against SARS-CoV-2 in the tribal population of Odisha. The vaccination coverage is at par with the general population, and efforts to address some knowledge gaps may be needed to improve the coverage in the future. |
format | Online Article Text |
id | pubmed-10057376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-100573762023-03-30 Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave Kshatri, Jaya Singh Bhattacharya, Debdutta Giri, Sidhartha Palo, Subrata Kumar Kanungo, Srikanta Mansingh, Asit Parai, Debaprasad Dany, Subha Soumya Bisoyee, Anjan Choudhary, Hari Ram Sinha, Abhinav Sahoo, Rakesh Kumar Bhoi, Trilochan Mohanta, Amiya Ranjan Ota, Akhila Bihari Mohanty, Bigyanananda Sahoo, Uttam Kumar Pati, Sanghamitra Indian J Med Res Programme: Original Article BACKGROUND & OBJECTIVES: Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated the seroprevalence of COVID-19 antibodies in the tribal population of Odisha post-second wave (September 2021). METHODS: A population-based, age-stratified, cross-sectional study design was adopted for the survey, carried out in seven tribal districts of Odisha from 30(th) August to 16(th) September 2021. A multistage random sampling method was used where serum samples were tested for antibodies against the SARS-CoV-2 nucleocapsid (N) protein in each district, and a weighted seroprevalence with 95 per cent confidence interval (CI) was estimated for each district. RESULTS: A total of 2855 study participants were included from the seven tribal districts of Odisha in the final analysis. The overall weighted seroprevalence was 72.8 per cent (95% CI: 70.1-75.3). Serological prevalence was the highest among 18-44 yr (74.4%, 95% CI: 71.3-77.3) and from Sambalpur district [75.90% (66.90-83.10)]. Among participants, 41.93 per cent had received at least one dose of any COVID-19 vaccine. Kandhamal district had the highest number of fully immunized participants (24.78%), and in Sundergarh district, most of the study participants (58.1%) were unimmunized. INTERPRETATION & CONCLUSIONS: This study found high seroprevalence against SARS-CoV-2 in the tribal population of Odisha. The vaccination coverage is at par with the general population, and efforts to address some knowledge gaps may be needed to improve the coverage in the future. Wolters Kluwer - Medknow 2022-08 2023-01-05 /pmc/articles/PMC10057376/ /pubmed/36629188 http://dx.doi.org/10.4103/ijmr.ijmr_3428_21 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Programme: Original Article Kshatri, Jaya Singh Bhattacharya, Debdutta Giri, Sidhartha Palo, Subrata Kumar Kanungo, Srikanta Mansingh, Asit Parai, Debaprasad Dany, Subha Soumya Bisoyee, Anjan Choudhary, Hari Ram Sinha, Abhinav Sahoo, Rakesh Kumar Bhoi, Trilochan Mohanta, Amiya Ranjan Ota, Akhila Bihari Mohanty, Bigyanananda Sahoo, Uttam Kumar Pati, Sanghamitra Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave |
title | Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave |
title_full | Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave |
title_fullStr | Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave |
title_full_unstemmed | Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave |
title_short | Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave |
title_sort | serological survey for sars-cov-2 antibodies among tribal communities of odisha post-second wave |
topic | Programme: Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057376/ https://www.ncbi.nlm.nih.gov/pubmed/36629188 http://dx.doi.org/10.4103/ijmr.ijmr_3428_21 |
work_keys_str_mv | AT kshatrijayasingh serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT bhattacharyadebdutta serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT girisidhartha serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT palosubratakumar serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT kanungosrikanta serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT mansinghasit serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT paraidebaprasad serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT danysubhasoumya serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT bisoyeeanjan serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT choudharyhariram serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT sinhaabhinav serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT sahoorakeshkumar serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT bhoitrilochan serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT mohantaamiyaranjan serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT otaakhilabihari serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT mohantybigyanananda serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT sahoouttamkumar serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT patisanghamitra serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave AT serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave |